Patent · US Active

Engineered deoxyribose-phosphate aldolases

US11845968B2 · kind B2 · utility

0Cited by
135References
14Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 4, 2022
Grant dateDec 19, 2023
Priority date
Expiry dateFeb 4, 2042

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12Y401/02004
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

The present invention provides engineered deoxyribose-phosphate aldolase polypeptides useful under industrial process conditions for the production of pharmaceutical and fine chemical compounds.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.